| Ticker Symbol: | AZN |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 15 Stanhope Gate London, EN W1K 1LN |
| CEO/President: | David R. Brennan |
| Industry: | Drug Manufacturers Major / Standard Industry Code: 2834 |
| Description: | A pharmaceutical company, which provides a range of medicines designed to fight disease in important areas of healthcare. |
| Shares Outstanding: | 1,457,062 (000) | Market Value: | 61,968,860 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 8.7% | Number of Inst.Shareholders: | 279 |
| Last Quarter Sales: | 7677.0 ($Mil.) | Last Quarter Net Income: | 1503.0 ($Mil.) |
| Last Quarter EPS: | 1.03 | P/E Ratio: | 11.4 |
| Most Recent Earnings: | 1.03 on 04/24/08 | Earnings Per Share: | 3.74 |
| Most Recent Split: | Annual Dividend Rate: | 1.87 | |
| Most Recent Dividend: | 1.350 on 02/07/08 | Annual Dividend Yield: | 4.4% |


| PFIZER INC | -30.20 | 17.75 | |
| MERCK CO INC | -24.40 | 38.45 | |
| BRISTOL MYERS S | -30.60 | 20.78 | |
| SCHERING PLOUGH | -30.90 | 19.79 | |
| WYETH | -8.20 | 46.99 |
